Serious Gaming for Chemotherapy-induced Nausea and Vomiting
Serious Gaming for Chemotherapy-induced Nausea and Vomiting in Older Adults With Cancer: A Randomized Clinical Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Victoria Loerzel, PhD
- Phone Number: 407-823-0762
- Email: victoria.loerzel@ucf.edu
Study Contact Backup
- Name: Michael Owings
- Phone Number: 407-440-1309
- Email: michaelowings@ucf.edu
Study Locations
-
-
Florida
-
Miami, Florida, United States, 33136
- Recruiting
- Miller School of Medicine Sylvester Comp. Cancer Center
-
Contact:
- Deborah Anglade, PhD
- Email: d.anglade@miami.edu
-
Orlando, Florida, United States, 32806
- Recruiting
- Orlando Health
-
Contact:
- Aurea Middleton, MSN
- Email: aurea.middleton@orlandohealth.com
-
Sub-Investigator:
- Aurea Middleton, MSN
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- age 60 or older
- newly diagnosed with cancer
- treatment with any chemotherapeutic agent of moderate or high emetic potential
- on a 2, 3 or 4 week treatment cycle
- proficient in English
- has a telephone
Exclusion Criteria:
- previous diagnosis and/or treatment for cancer
- end stage disease with less than 6 months to live
- visually or hearing impaired without corrective device
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Intervention
This intervention is a serious game which allows older adults under treatment for cancer to practice making self-care decisions for an avatar that is being sent home after their first chemotherapy treatment.
This serious game is coupled with a discussion with the research assistant about choices related to managing nausea and vomiting at home
|
Participants in the intervention group will be asked to play the serious game on an iPad at their first chemotherapy treatment visit.
The control group will be able to play at time 6.
Other Names:
|
|
Active Comparator: Control
The control group will receive standard education related to managing nausea and vomiting and will have the opportunity to participate in the intervention at the end of the study
|
Participants in the intervention group will be asked to play the serious game on an iPad at their first chemotherapy treatment visit.
The control group will be able to play at time 6.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Healthcare resource use
Time Frame: From baseline through the end of the study at 12 or 24 weeks
|
any emergency department or hospital admission will be recorded using a dichotomous variable (yes/no)
|
From baseline through the end of the study at 12 or 24 weeks
|
|
CINV severity
Time Frame: From baseline1 through the end of the study at 12 or 24 weeks
|
The Symptom Management Checklist will measure the presence and severity of nausea and vomiting.
Participants will be sent a text link every day for 6 days after chemotherapy or complete this data on a form at home.
This starts right after time 1.
Nausea will be reported on a 0-10 scale.
Higher numbers equal more nausea.
|
From baseline1 through the end of the study at 12 or 24 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-management behaviors
Time Frame: From baseline through the end of the study at 12 or 24 weeks
|
The Symptom Management Checklist will measure self-management behaviors and preventive behaviors for CINV.
Participants will be sent a text link every day for 6 days after chemotherapy or complete this data on a form at home.
This starts right after Time 1.
|
From baseline through the end of the study at 12 or 24 weeks
|
|
Health-related Quality of Life
Time Frame: baseline, 4,8,12,16,20, and 24 weeks
|
The EORTC-30 will measure quality of life at each treatment cycle.
Higher scores mean better quality of life
|
baseline, 4,8,12,16,20, and 24 weeks
|
|
Symptom severity
Time Frame: Baseline and 12 or 24 weeks
|
The Symptom Representation Questionnaire Part 1 is a 24 item self-report measure that will be used to identify the presence and severity of common treatment-related side effects (0 to 10 scale).
Higher numbers indicate more severe symptoms.
This measure asks participants to think about their symptoms over the last week
|
Baseline and 12 or 24 weeks
|
|
Cognitive representation
Time Frame: Baseline and 12 or 24 weeks
|
The Symptom Representation Questionnaire Part 2 has 15 questions related to cognitive beliefs about nausea.
Sub scales examine symptom cause, timeline, cure/control, and consequences.
An agreement type Likert scale is used.
|
Baseline and 12 or 24 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Victoria Loerzel, PhD, University of Central Florida
Publications and helpful links
General Publications
- Loerzel V. Cognitive Representation of Treatment-Related Symptoms in Older Adults With Cancer. Cancer Nurs. 2017 May/Jun;40(3):230-236. doi: 10.1097/NCC.0000000000000395.
- Loerzel V, Clochesy J, Geddie P. Using a community advisory board to develop a serious game for older adults undergoing treatment for cancer. Appl Nurs Res. 2018 Feb;39:207-210. doi: 10.1016/j.apnr.2017.11.030. Epub 2017 Nov 21.
- Loerzel VW, Hines RB, Deatrick CW, Geddie PI, Clochesy JM. Unplanned emergency department visits and hospital admissions of older adults under treatment for cancer in the ambulatory/community setting. Support Care Cancer. 2021 Dec;29(12):7525-7533. doi: 10.1007/s00520-021-06338-y. Epub 2021 Jun 9.
- Wochna Loerzel V, Clochesy JM, Geddie PI. Using Serious Games to Increase Prevention and Self-Management of Chemotherapy-Induced Nausea and Vomiting in Older Adults With Cancer. Oncol Nurs Forum. 2020 Sep 1;47(5):567-576. doi: 10.1188/20.ONF.567-576.
- Loerzel V, Alamian A, Clochesy J, Geddie PI. Serious Gaming for Chemotherapy-Induced Nausea and Vomiting in Older Adults With Cancer: Protocol for a Randomized Clinical Trial. JMIR Res Protoc. 2024 Oct 2;13:e64673. doi: 10.2196/64673.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 00003808
- R01NR020003 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.